<DOC>
	<DOCNO>NCT00747357</DOCNO>
	<brief_summary>The INDICOR study control , prospective , multicenter , randomize , two arm phase-II real world study assess acute , 6 month , 12 month 3 year outcome cobalt-chromium stent ( Coroflex Blue ) deployment follow Paclitaxel-eluting PTCA-balloon dilatation ( SeQuent Please ) Paclitaxel-eluting PTCA-balloon dilatation ( SeQuent Please ) follow cobalt-chromium stent ( Coroflex Blue ) deployment treatment de-novo restenotic lesion native coronary artery . The study conduct India .</brief_summary>
	<brief_title>INDICOR The Paclitaxel-Eluting PTCA-Balloon Catheter Combination With Cobalt-Chromium Stent</brief_title>
	<detailed_description>The aim study evaluate efficacy safety cobalt-chromium stent ( Coroflex Blue ) deployment follow Paclitaxel-eluting PTCA-balloon dilatation ( SeQuent Please ) Paclitaxel-eluting PTCA-balloon dilatation ( SeQuent Please ) follow cobalt-chromium stent ( Coroflex Blue ) deployment real world scenario include two de-novo restenotic lesion ( in-stent restenoses ) two different native coronary artery ( reference diameter : 2.5mm 4.0mm , length stenosis 10mm 25mm ) procedural success preservation vessel patency 3 year</detailed_description>
	<mesh_term>Heart Diseases</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Paclitaxel</mesh_term>
	<mesh_term>Chromium</mesh_term>
	<mesh_term>Cobalt</mesh_term>
	<criteria>Patients stable angina pectoris ( CCS class 13 ) unstable angina pectoris ( Braunwald class 12 , AC ) document ischemia document silent ischemia Patients eligible coronary revascularization mean PCI Patients suitable coronary revascularization sort ( balloon angioplasty , deviceassisted balloonangioplasty coronary artery bypass graft ) Patients must older 18 year age Women childbearing potential may pregnant desire become pregnant first year follow study procedure . Hence , patient advise use adequate birth control method include 6 month followup . Patients mentally linguistically able understand aim study show sufficient compliance follow study protocol Patients must agree undergo 6 month angiographic followup Patients must agree undergo 1 year 3 year clinical followup Lesion Related ( relate 2 stenosis two different coronary artery treat per protocol ) Reference diameter range 2.5 mm 4.0 mm length stenosis 10 mm ≤ 25 mm Diameter stenosis pre procedure must either 70 % 50 % ischemia correspond target lesion document either exercise stress ECG , stress echocardiography , scintigraphy Coverage target lesion must intend possible single Paclitaxeleluting balloon Patient Related Patients acute ( &lt; 24 h ) recent ( ≤ 48 hour ) myocardial infarction Patients unstable angina pectoris ( Braunwald class 3 ) Patients severe congestive heart failure Patients severe heart failure NYHA IV Patients demonstrate clinical sign cardiogenic shock time procedure ( systolic blood pressure le 80 mm Hg require inotropic support , IABP and/or fluid challenge ) . Patients severe valvular heart disease Women pregnant lactating Patients life expectancy less five year factor make clinical followup difficult Patients bleed diathesis anticoagulation antiplatelet medication contraindicate Patients cerebral stroke &lt; 6 month prior procedure Patient participate clinical trial involve investigational device drug Untreated hyperthyroidism Patient presence history severe renal failure ( GFR &lt; 30ml/min ) therefore eligible angiography . Patient 's serum creatinine level must document Post transplantation organ immune suppressive medication Other disease jeopardize followup ( e.g. , malignancy ) Addiction drug alcohol Patients type surgery week precede interventional procedure Patients percutaneous coronary intervention six month prior enrollment study Lesion Related Evidence extensive thrombosis within target vessel intervention Side branch &gt; 2 mm diameter originate lesion Percutaneous coronary intervention venous graft Target segment occlude ( i.e. , acute chronic ) Instent restenosis ( restenoses nonstented segment permit ) Ostial lesion within 2 mm vessel origin Patients another coronary stent implant previously target vessel proximal target lesion</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2016</verification_date>
</DOC>